International Procurement Instrument: European Parliament moves forward
Posted on 04.11.2021
The International Trade Committee of the European Parliament (INTA) met on 26 October to discuss the amendments tabled to the Commission proposal and the legislative report on the International Procurement Instrument (IPI). More than 500 amendments were received. The vote is expected to take place at the meeting on 29-30 November.
The other Committee involved in the development of IPI is the Internal Market & Consumer Protection Committee (IMCO) and voted on its amendments on 27 October.
While some details need to be further discussed (e.g., price adjustment mechanism), consensus on the main points emerged from all sides of the hemicycle: once adopted, the IPI would represent an essential part of EU’s toolbox helping companies to compete abroad.
MedTech Europe’s International Affairs team is closely monitoring the debates and activities related to the IPI: European companies in the medical technology sector are confronted with challenging access to the procurement markets in third countries due to lack of transparency and local content requirements in public tenders.
For more information, please contact Dario Belluomini, Manager International Affairs